|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
0 |
10/04/26 |
| 10/04/26 |
ASX - By Stock
|
290
|
86K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
1 |
10/04/26 |
| 10/04/26 |
ASX - By Stock
|
290
|
86K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
0 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
290
|
86K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
0 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
290
|
86K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
1 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
290
|
86K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
1 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
290
|
86K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
3 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
290
|
86K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
3 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
290
|
86K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
0 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
290
|
86K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
2 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
290
|
86K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
1 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
290
|
86K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
7 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
290
|
86K
|
7
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
9 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
290
|
86K
|
9
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Kohbee
|
290 |
86K |
7 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
290
|
86K
|
7
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Clears Ryoncil IND for Registration Trial in DMD
|
|
Kohbee
|
40 |
16K |
0 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
40
|
16K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Clears Ryoncil IND for Registration Trial in DMD
|
|
Kohbee
|
40 |
16K |
3 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
40
|
16K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Kohbee
|
21K |
9.0M |
16 |
01/04/26 |
| 01/04/26 |
ASX - By Stock
|
21K
|
9.0M
|
16
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Kohbee
|
21K |
9.0M |
0 |
01/04/26 |
| 01/04/26 |
ASX - By Stock
|
21K
|
9.0M
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
R&D day
|
|
Kohbee
|
155 |
63K |
4 |
01/04/26 |
| 01/04/26 |
ASX - By Stock
|
155
|
63K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to Host R&D Day on April 8, 2026
|
|
Kohbee
|
163 |
60K |
22 |
19/03/26 |
| 19/03/26 |
ASX - By Stock
|
163
|
60K
|
22
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Corporate Presentation and Half Year Financial Results
|
|
Kohbee
|
87 |
32K |
2 |
04/03/26 |
| 04/03/26 |
ASX - By Stock
|
87
|
32K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Corporate Presentation and Half Year Financial Results
|
|
Kohbee
|
87 |
32K |
4 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
87
|
32K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Corporate Presentation and Half Year Financial Results
|
|
Kohbee
|
87 |
32K |
11 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
87
|
32K
|
11
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Corporate Presentation and Half Year Financial Results
|
|
Kohbee
|
87 |
32K |
3 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
87
|
32K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Corporate Presentation and Half Year Financial Results
|
|
Kohbee
|
87 |
32K |
3 |
01/03/26 |
| 01/03/26 |
ASX - By Stock
|
87
|
32K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2026 Half Year Financial Results Webcast
|
|
Kohbee
|
67 |
29K |
4 |
26/02/26 |
| 26/02/26 |
ASX - By Stock
|
67
|
29K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2026 Half Year Financial Results Webcast
|
|
Kohbee
|
67 |
29K |
0 |
25/02/26 |
| 25/02/26 |
ASX - By Stock
|
67
|
29K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2026 Half Year Financial Results Webcast
|
|
Kohbee
|
67 |
29K |
5 |
25/02/26 |
| 25/02/26 |
ASX - By Stock
|
67
|
29K
|
5
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2026 Half Year Financial Results Webcast
|
|
Kohbee
|
67 |
29K |
6 |
25/02/26 |
| 25/02/26 |
ASX - By Stock
|
67
|
29K
|
6
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2026 Half Year Financial Results Webcast
|
|
Kohbee
|
67 |
29K |
2 |
24/02/26 |
| 24/02/26 |
ASX - By Stock
|
67
|
29K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2026 Half Year Financial Results Webcast
|
|
Kohbee
|
67 |
29K |
14 |
24/02/26 |
| 24/02/26 |
ASX - By Stock
|
67
|
29K
|
14
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2026 Half Year Financial Results Webcast
|
|
Kohbee
|
67 |
29K |
24 |
24/02/26 |
| 24/02/26 |
ASX - By Stock
|
67
|
29K
|
24
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kohbee
|
21K |
7.7M |
5 |
21/02/26 |
| 21/02/26 |
ASX - By Stock
|
21K
|
7.7M
|
5
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2026 Half Year Financial Results Webcast
|
|
Kohbee
|
67 |
29K |
3 |
21/02/26 |
| 21/02/26 |
ASX - By Stock
|
67
|
29K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kohbee
|
21K |
7.7M |
3 |
17/02/26 |
| 17/02/26 |
ASX - By Stock
|
21K
|
7.7M
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kohbee
|
21K |
7.7M |
5 |
17/02/26 |
| 17/02/26 |
ASX - By Stock
|
21K
|
7.7M
|
5
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Kohbee
|
21K |
9.0M |
1 |
16/02/26 |
| 16/02/26 |
ASX - By Stock
|
21K
|
9.0M
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Real World Experience with Ryoncil Shows 84% Early Survival
|
|
Kohbee
|
126 |
38K |
0 |
28/01/26 |
| 28/01/26 |
ASX - By Stock
|
126
|
38K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Real World Experience with Ryoncil Shows 84% Early Survival
|
|
Kohbee
|
126 |
38K |
17 |
28/01/26 |
| 28/01/26 |
ASX - By Stock
|
126
|
38K
|
17
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Real World Experience with Ryoncil Shows 84% Early Survival
|
|
Kohbee
|
126 |
38K |
19 |
28/01/26 |
| 28/01/26 |
ASX - By Stock
|
126
|
38K
|
19
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Release of Shares from Voluntary Escrow
|
|
Kohbee
|
6 |
3.1K |
1 |
30/12/25 |
| 30/12/25 |
ASX - By Stock
|
6
|
3.1K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Release of Shares from Voluntary Escrow
|
|
Kohbee
|
6 |
3.1K |
1 |
30/12/25 |
| 30/12/25 |
ASX - By Stock
|
6
|
3.1K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Release of Shares from Voluntary Escrow
|
|
Kohbee
|
6 |
3.1K |
0 |
30/12/25 |
| 30/12/25 |
ASX - By Stock
|
6
|
3.1K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Gregory George
|
|
Kohbee
|
17 |
7.5K |
22 |
26/12/25 |
| 26/12/25 |
ASX - By Stock
|
17
|
7.5K
|
22
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Gregory George
|
|
Kohbee
|
17 |
7.5K |
8 |
25/12/25 |
| 25/12/25 |
ASX - By Stock
|
17
|
7.5K
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kohbee
|
21K |
7.7M |
2 |
24/12/25 |
| 24/12/25 |
ASX - By Stock
|
21K
|
7.7M
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kohbee
|
21K |
7.7M |
7 |
24/12/25 |
| 24/12/25 |
ASX - By Stock
|
21K
|
7.7M
|
7
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kohbee
|
21K |
7.7M |
9 |
23/12/25 |
| 23/12/25 |
ASX - By Stock
|
21K
|
7.7M
|
9
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Kohbee
|
21K |
7.7M |
24 |
23/12/25 |
| 23/12/25 |
ASX - By Stock
|
21K
|
7.7M
|
24
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
Kohbee
|
916 |
291K |
4 |
09/12/25 |
| 09/12/25 |
ASX - By Stock
|
916
|
291K
|
4
|
|